SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 206 filers reported holding SAGE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,618,913 | +100987.0% | 94,885 | +3.8% | 0.00% | 0.0% |
| Q3 2022 | $3,580 | +25.3% | 91,395 | +3.3% | 0.00% | +33.3% |
| Q2 2022 | $2,857 | -12.6% | 88,446 | -10.4% | 0.00% | +50.0% |
| Q1 2022 | $3,269 | -15.0% | 98,766 | +9.3% | 0.00% | 0.0% |
| Q4 2021 | $3,845 | +0.5% | 90,372 | +4.7% | 0.00% | 0.0% |
| Q3 2021 | $3,824 | -16.1% | 86,298 | +7.5% | 0.00% | 0.0% |
| Q2 2021 | $4,559 | -12.7% | 80,265 | +15.1% | 0.00% | -33.3% |
| Q1 2021 | $5,221 | +83.3% | 69,749 | +111.9% | 0.00% | +50.0% |
| Q4 2020 | $2,848 | +173.6% | 32,916 | +93.3% | 0.00% | +100.0% |
| Q3 2020 | $1,041 | +1477.3% | 17,030 | +971.1% | 0.00% | – |
| Q2 2020 | $66 | +164.0% | 1,590 | +80.9% | 0.00% | – |
| Q1 2020 | $25 | -28.6% | 879 | +79.4% | 0.00% | – |
| Q4 2019 | $35 | -49.3% | 490 | 0.0% | 0.00% | – |
| Q3 2019 | $69 | – | 490 | – | 0.00% | – |
Download | ||||||